<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Avisford Medical Group</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Avisford Medical Group is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0409010S0&amp;denomIds=4.9.1&amp;selectedTab=summary">Tolcapone</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>7</td>
      <td>Dopaminergic drugs used in parkinsonism</td>
      <td>434</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>26.96</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0409010S0AAAAAA&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Tolcapone 100mg tablets : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0402030R0&amp;denomIds=4.2.3&amp;selectedTab=summary">Asenapine</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>12</td>
      <td>Drugs used for mania and hypomania</td>
      <td>110</td>
      <td>0.11</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>22.81</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0402030R0AAAAAA&amp;denomIds=4.2.3&amp;selectedTab=summary" target="_blank">Asenapine 10mg sublingual tablets sugar free : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0402030R0AAABAB&amp;denomIds=4.2.3&amp;selectedTab=summary" target="_blank">Asenapine 5mg sublingual tablets sugar free : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0212000M0&amp;denomIds=2.12&amp;selectedTab=summary">Fluvastatin sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>142</td>
      <td>Lipid-regulating drugs</td>
      <td>7383</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>8.73</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0212000M0AAAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Fluvastatin 20mg capsules : 90</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0212000M0AAABAB&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Fluvastatin 40mg capsules : 48</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0212000M0AAADAD&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Fluvastatin 80mg modified-release tablets : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0106020J0&amp;denomIds=1.6.2&amp;selectedTab=summary">Co-danthrusate (Dantron/docusate sodium)</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Stimulant laxatives</td>
      <td>642</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>5.84</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0106020J0AAADAD&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Co-danthrusate 50mg/60mg/5ml oral suspension sugar free : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0601023AV&amp;denomIds=6.1.2&amp;selectedTab=summary">Saxagliptin/dapagliflozin</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>18</td>
      <td>Other antidiabetic drugs</td>
      <td>1354</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>4.03</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0601023AVBBAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Qtern 5mg/10mg tablets : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0601023AVAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Saxagliptin 5mg / Dapagliflozin 10mg tablets : 10</a></div></td></tr></tbody></table>

        <h2>Prescribing where Avisford Medical Group is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0605010S0&amp;denomIds=6.5.1&amp;selectedTab=summary">Somatropin</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Hypothalamic &amp; anterior pituitary hormone &amp; antioestrogens</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.90</td>
      <td>0.27</td>
      <td>-3.31</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1304000H0&amp;denomIds=13.4&amp;selectedTab=summary">Clobetasone butyrate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>37</td>
      <td>Topical corticosteroids</td>
      <td>829</td>
      <td>0.04</td>
      <td>0.13</td>
      <td>0.05</td>
      <td>-1.73</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1304000H0AACACA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Clobet 0.05%/Oxytetracycline 3% /Nystatin 100,000units/g crm : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1304000H0BBAAAA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Eumovate 0.05% cream : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1304000H0BBABBA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Eumovate 0.05% ointment : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1304000H0BCABCA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Trimovate cream : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1304000H0AAAAAA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Clobetasone 0.05% cream : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1304000H0AABABA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Clobetasone 0.05% ointment : 25</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1001022K0&amp;denomIds=10.1.2&amp;selectedTab=summary">Methylprednisolone acetate</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Local corticosteroid injections</td>
      <td>63</td>
      <td>0.06</td>
      <td>0.73</td>
      <td>0.39</td>
      <td>-1.71</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1001022K0BBAAAA&amp;denomIds=10.1.2&amp;selectedTab=summary" target="_blank">Depo-Medrone 40mg/1ml suspension for injection vials : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1001022K0AAAAAA&amp;denomIds=10.1.2&amp;selectedTab=summary" target="_blank">Methylprednisolone acetate 40mg/1ml inj vials : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=1001022K0AAABAB&amp;denomIds=10.1.2&amp;selectedTab=summary" target="_blank">Methylprednisolone acetate 80mg/2ml inj vials : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0206020A0&amp;denomIds=2.6.2&amp;selectedTab=summary">Amlodipine</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2322</td>
      <td>Calcium-channel blockers</td>
      <td>4081</td>
      <td>0.57</td>
      <td>0.75</td>
      <td>0.11</td>
      <td>-1.63</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAIK0lEQVR4nO2dbaxcRRmAn7ncYluxkBYEkdIjDcRgQCzEUFGsivhxakOQIha5Co1NEMRoJfcgIK2NYQoRDR9SUGvDDwhCtQinCUESFU2uioGmapRIO4AoVlo/+GwRxh8z1e2yt+7du+fM2Zn3SSY9e9t73ne3++ycM/POrLLWIghCGgyFTkAQhPoQ4QUhIUR4QUgIEV4QEkKEF4SEEOEFISFEeEFICBFeEBJChBeEhBDhBSEhRPgYUUrqpYWODIdOQBD6TVaUM4EFwHxgNnAoMB142reHgfuAzUbnrwRKMwhKFs9EiFIWa1XoNOokK8oZwFnAecCBwE+AB4CtwF+A54FZwOuBtwPvBzJgHfBNo/NttScdABE+RhISPivKNwAFcDrwA+A7RuebuvzdA4HzgaXARuAKo/O/VZVrExDhYyQB4bOiPAC4FFgMXAusMTp/vsdzTQUuAD4LfA240ej83/3KtUmI8DESsfBZUSrgbGAVsBb4utH5s3069yGABt4MfNLo/A/9OG+TEOFjJFLhs6I8Avg28BxwkdH51oriLMRdNVwD3GB0Ho0kInyMRCZ8VpRDwGeA5cAocEfVEmZFeRDuw+Vl4Fyj839WGa8uRPgYiUj4rCjn4i7dnwIurHNQzd8+fBE38n9Wt4OBTUaEj5EIhM+Kch/cQNrngYuNzu8MmMvJwHeB5UbnG0Ll0Q9E+BgZcOGzopwH3Ag8CnyuCVNlWVHOAX4I3ApcNaj39SJ8jAyo8L54ZhVwKm5Q7r7AKe2Bz+824EngfKPzlwOnNGFE+BgZMOH9vfKZwJW4yrerjM5fDJrUOGRFOYwbzHst8Amj852BU5oQInyMDJDwWVEeCVzvH15gdP7HkPl0g581uBo4FjjN6Py5wCl1jQgfIwMgfFaUr8GVxI4Al1DDVFs/8VcllwHvARb2WuVXNyJ8jDRc+KwoT8BNtf0YuMzo/F9hM+qdrChXACcBi4zOXwiczv9FhI+Rhgrve/UvAx8FPm10/kDglCaN7+lXASfgLu8bOfawG9kAQ6gF36v/CjfYNS8G2QH8bcjluDX26/2HWmORHj5GGtTDx9ird8L39FcDRwFnGJ3vCpxSR6SHFyqjpVffDzg+Vtnhvz39xcAW4HtZUe4bOKWOSA8fI4F7eF+gcgWQA8uMzn8aKpe68T39tcAbgY8Znb8UOKU9EOFjJJDwfn76bGAlcAuwehBGrvuNl/564GDg402SXoSPkZqF96KfgRu8+j0wanS+pa74TcS/Jjfg9tFb0pQddET4GKlJeH/pPoJbq/47YKXR+eaq4w4KXvo1wOuAc5ogvQgfIxUK7y9XT8KJ/kHgTtyur40viQ2Bl/5m3HTkSOjLexE+RioQ3m9EcQ6wBLf18y3AhkGqIw+Fl/464Ahgcb/24OsFET5G+iS83xn2TFxvvj9O8luNzp+c7LlTw18ZXQp8BMiNzp8OkYcIHyOTED4ryim49egjwInA93GiPzxIi1uaSlaUS3Hz9YtDjHeI8DEyQeH9Gu8FuGq4DwO/wEl+b+h7zhjxW2atw81m3FFnbBE+RroQ3pe8vhcn+QeAB4H1wN2x7NDaZLKinI17vcdw4tdSryDCx0gH4f3A0VuB9wGnAMcAP8eNsm8MOZCUKv5DdyWuInHE6PyhqmOK8DGilM1G7zkMJ/hxwDzc/fgjwI+A+4FfN2FeWICsKN8NfAu4C/iK0fkzVcUS4QeUrCinAYf5NrulzTWrF56Sjd6zCbdkc3f75aDsypIiWVFOx+38swS3DuG2KjbJFOEbiq9iy3x7U8vxHOAQYBfwJ+CJlj+fALaa1QsfasryWGFi+D3+VuFuub4K3N5P8UX4APh7t1m43vnwtjYHOBR4FlfgYtraY8BTe30TNGg9vNAbWVEejdsz70TcjMlao/PHJ3teEb5H/Hz1frg66RnAzJY2a5zjmcAUYCewHbe/+eMd2p+Nzl/pOTkRPhr8N9p+CjgX2IG7zy+B3/byHolCeF/FtC8wDZja0ibzuPV4Ov+TeypggZdwvfAzvm3H/Yfs2MvxjlrmtUX46PDv8aOBRbg1DEcCm4AHjc4v7/Y8ExI+K8ovAfu0tKG2x+0/G+7xeHicNsX/fWvSyj/eCbzo2wtdHE/03+0We1fjK85E+OjxO+q8DTjO6Pymrn/RWtuYBixLLXZqcVN8ziFf6/bWtD3tliUYO7W4IWOnFvdVNE14QRAqRIQXhIRomvA3Jxg7tbghY6cW91VEMS0nCEJ3NK2HFwShQoZDJ6CUOhl4B7DNWrtWKfUh3PziZmvt3XXF9T9bA6yz1o7VFVcptQL4B7DRWvtIVXHHif0uYD4wZq2t7MsiOsQ9DVdEMs1a23XRSB/iLsUVT2Gt/UZVcceJfR5wAPCYtXZ9lbH3RhN6+PnWWg0c5B+P4VZ9Vf0tnHvEVUqdjvv64qppf77bcTua1kF77EW4oqLey3h7iGut3QA8CtxeZ1xc0dbBwLaK43aKfbi19hpclVwwmiD8HoMI1tq/AxfidvisLS5wLPBO3BbMtcW11l4HXIn7IoeqaX/OM3z8U2uOC3CMtfY3NccdstZeAsytOG6n2PcrpS4Cgu4mFPySHhhTSo0CO5RSx+M2bJiL6+lri2utXaGUWkD1Vxbtz/co4C3AzyqO2yn2vUqpL+BW4NUZdwtubUHVtMedrpRaDvw1QOwh3DqMu2qIPS4ySi8ICdGES3pBEGpChBeEhBDhBSEhRHhBSAgRXhASQoQXhIQQ4QUhIUR4QUgIEV4QEkKEF4SEEOEFISH+AwE9RjMxxJ9VAAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0206020A0AAAAAA&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Amlodipine 5mg tablets : 1467</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0206020A0AAABAB&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Amlodipine 10mg tablets : 842</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0206020A0AAAVAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Amlodipine 2.5mg tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0206020A0AAATAT&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Amlodipine 10mg/5ml oral solution sugar free : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0206020A0AAALAL&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Amlodipine 5mg/5ml oral solution sugar free : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0105020A0&amp;denomIds=1.5.2&amp;selectedTab=summary">Budesonide</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Corticosteroids</td>
      <td>17</td>
      <td>0.24</td>
      <td>0.70</td>
      <td>0.34</td>
      <td>-1.38</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0105020A0BEAAAG&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Jorveza 1mg orodispersible tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0105020A0AAAAAA&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Budesonide 3mg gastro-resistant modified-release capsules : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82048&amp;numIds=0105020A0AAACAC&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Budesonide 3mg gastro-resistant capsules : 1</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>